Global Kidney & Renal Fibrosis Treatment Market Research Report 2023
This report aims to provide a comprehensive presentation of the global market for Kidney & Renal Fibrosis Treatment, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Kidney & Renal Fibrosis Treatment.
The Kidney & Renal Fibrosis Treatment market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2022 as the base year, with history and forecast data for the period from 2018 to 2029. This report segments the global Kidney & Renal Fibrosis Treatment market comprehensively. Regional market sizes, concerning products by type, by application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Kidney & Renal Fibrosis Treatment companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by type, by application, and by regions.
By Company
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Kidney & Renal Fibrosis Treatment companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the key companies in the market in detail, including product revenue, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
The Kidney & Renal Fibrosis Treatment market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2022 as the base year, with history and forecast data for the period from 2018 to 2029. This report segments the global Kidney & Renal Fibrosis Treatment market comprehensively. Regional market sizes, concerning products by type, by application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Kidney & Renal Fibrosis Treatment companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by type, by application, and by regions.
By Company
- Galectin Therapeutics
- Merck & Co.
- F. Hoffman-La Roche Ltd.
- Pfizer Inc.
- InterMune Inc.
- ProMetic Life-Sciences Inc.
- La Jolla Pharmaceutical Company
- Genzyme Corporation
- BioLine Rx Ltd
- Angiotensin II Receptor Blockers (ARBs)
- Angiotensin Converting Enzyme (ACE) Inhibitors
- Pirfenidone
- Renin Inhibitors
- Vasopeptidase Inhibitors
- Commercial/Private Hospitals
- Public Health Hospitals
- Clinics
- Home Treatment
- North America
- United States
- Canada
- Europe
- Germany
- France
- UK
- Italy
- Russia
- Nordic Countries
- Rest of Europe
- Asia-Pacific
- China
- Japan
- South Korea
- Southeast Asia
- India
- Australia
- Rest of Asia
- Latin America
- Mexico
- Brazil
- Rest of Latin America
- Middle East & Africa
- Turkey
- Saudi Arabia
- UAE
- Rest of MEA
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Kidney & Renal Fibrosis Treatment companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the key companies in the market in detail, including product revenue, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
1 REPORT OVERVIEW
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Kidney & Renal Fibrosis Treatment Market Size Growth Rate by Type: 2018 VS 2022 VS 2029
1.2.2 Angiotensin II Receptor Blockers (ARBs)
1.2.3 Angiotensin Converting Enzyme (ACE) Inhibitors
1.2.4 Pirfenidone
1.2.5 Renin Inhibitors
1.2.6 Vasopeptidase Inhibitors
1.3 Market by Application
1.3.1 Global Kidney & Renal Fibrosis Treatment Market Growth by Application: 2018 VS 2022 VS 2029
1.3.2 Commercial/Private Hospitals
1.3.3 Public Health Hospitals
1.3.4 Clinics
1.3.5 Home Treatment
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 GLOBAL GROWTH TRENDS
2.1 Global Kidney & Renal Fibrosis Treatment Market Perspective (2018-2029)
2.2 Kidney & Renal Fibrosis Treatment Growth Trends by Region
2.2.1 Global Kidney & Renal Fibrosis Treatment Market Size by Region: 2018 VS 2022 VS 2029
2.2.2 Kidney & Renal Fibrosis Treatment Historic Market Size by Region (2018-2023)
2.2.3 Kidney & Renal Fibrosis Treatment Forecasted Market Size by Region (2024-2029)
2.3 Kidney & Renal Fibrosis Treatment Market Dynamics
2.3.1 Kidney & Renal Fibrosis Treatment Industry Trends
2.3.2 Kidney & Renal Fibrosis Treatment Market Drivers
2.3.3 Kidney & Renal Fibrosis Treatment Market Challenges
2.3.4 Kidney & Renal Fibrosis Treatment Market Restraints
3 COMPETITION LANDSCAPE BY KEY PLAYERS
3.1 Global Top Kidney & Renal Fibrosis Treatment Players by Revenue
3.1.1 Global Top Kidney & Renal Fibrosis Treatment Players by Revenue (2018-2023)
3.1.2 Global Kidney & Renal Fibrosis Treatment Revenue Market Share by Players (2018-2023)
3.2 Global Kidney & Renal Fibrosis Treatment Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Kidney & Renal Fibrosis Treatment Revenue
3.4 Global Kidney & Renal Fibrosis Treatment Market Concentration Ratio
3.4.1 Global Kidney & Renal Fibrosis Treatment Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Kidney & Renal Fibrosis Treatment Revenue in 2022
3.5 Kidney & Renal Fibrosis Treatment Key Players Head office and Area Served
3.6 Key Players Kidney & Renal Fibrosis Treatment Product Solution and Service
3.7 Date of Enter into Kidney & Renal Fibrosis Treatment Market
3.8 Mergers & Acquisitions, Expansion Plans
4 KIDNEY & RENAL FIBROSIS TREATMENT BREAKDOWN DATA BY TYPE
4.1 Global Kidney & Renal Fibrosis Treatment Historic Market Size by Type (2018-2023)
4.2 Global Kidney & Renal Fibrosis Treatment Forecasted Market Size by Type (2024-2029)
5 KIDNEY & RENAL FIBROSIS TREATMENT BREAKDOWN DATA BY APPLICATION
5.1 Global Kidney & Renal Fibrosis Treatment Historic Market Size by Application (2018-2023)
5.2 Global Kidney & Renal Fibrosis Treatment Forecasted Market Size by Application (2024-2029)
6 NORTH AMERICA
6.1 North America Kidney & Renal Fibrosis Treatment Market Size (2018-2029)
6.2 North America Kidney & Renal Fibrosis Treatment Market Growth Rate by Country: 2018 VS 2022 VS 2029
6.3 North America Kidney & Renal Fibrosis Treatment Market Size by Country (2018-2023)
6.4 North America Kidney & Renal Fibrosis Treatment Market Size by Country (2024-2029)
6.5 United States
6.6 Canada
7 EUROPE
7.1 Europe Kidney & Renal Fibrosis Treatment Market Size (2018-2029)
7.2 Europe Kidney & Renal Fibrosis Treatment Market Growth Rate by Country: 2018 VS 2022 VS 2029
7.3 Europe Kidney & Renal Fibrosis Treatment Market Size by Country (2018-2023)
7.4 Europe Kidney & Renal Fibrosis Treatment Market Size by Country (2024-2029)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 ASIA-PACIFIC
8.1 Asia-Pacific Kidney & Renal Fibrosis Treatment Market Size (2018-2029)
8.2 Asia-Pacific Kidney & Renal Fibrosis Treatment Market Growth Rate by Region: 2018 VS 2022 VS 2029
8.3 Asia-Pacific Kidney & Renal Fibrosis Treatment Market Size by Region (2018-2023)
8.4 Asia-Pacific Kidney & Renal Fibrosis Treatment Market Size by Region (2024-2029)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 LATIN AMERICA
9.1 Latin America Kidney & Renal Fibrosis Treatment Market Size (2018-2029)
9.2 Latin America Kidney & Renal Fibrosis Treatment Market Growth Rate by Country: 2018 VS 2022 VS 2029
9.3 Latin America Kidney & Renal Fibrosis Treatment Market Size by Country (2018-2023)
9.4 Latin America Kidney & Renal Fibrosis Treatment Market Size by Country (2024-2029)
9.5 Mexico
9.6 Brazil
10 MIDDLE EAST & AFRICA
10.1 Middle East & Africa Kidney & Renal Fibrosis Treatment Market Size (2018-2029)
10.2 Middle East & Africa Kidney & Renal Fibrosis Treatment Market Growth Rate by Country: 2018 VS 2022 VS 2029
10.3 Middle East & Africa Kidney & Renal Fibrosis Treatment Market Size by Country (2018-2023)
10.4 Middle East & Africa Kidney & Renal Fibrosis Treatment Market Size by Country (2024-2029)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 KEY PLAYERS PROFILES
11.1 Galectin Therapeutics
11.1.1 Galectin Therapeutics Company Detail
11.1.2 Galectin Therapeutics Business Overview
11.1.3 Galectin Therapeutics Kidney & Renal Fibrosis Treatment Introduction
11.1.4 Galectin Therapeutics Revenue in Kidney & Renal Fibrosis Treatment Business (2018-2023)
11.1.5 Galectin Therapeutics Recent Development
11.2 Merck & Co.
11.2.1 Merck & Co. Company Detail
11.2.2 Merck & Co. Business Overview
11.2.3 Merck & Co. Kidney & Renal Fibrosis Treatment Introduction
11.2.4 Merck & Co. Revenue in Kidney & Renal Fibrosis Treatment Business (2018-2023)
11.2.5 Merck & Co. Recent Development
11.3 F. Hoffman-La Roche Ltd.
11.3.1 F. Hoffman-La Roche Ltd. Company Detail
11.3.2 F. Hoffman-La Roche Ltd. Business Overview
11.3.3 F. Hoffman-La Roche Ltd. Kidney & Renal Fibrosis Treatment Introduction
11.3.4 F. Hoffman-La Roche Ltd. Revenue in Kidney & Renal Fibrosis Treatment Business (2018-2023)
11.3.5 F. Hoffman-La Roche Ltd. Recent Development
11.4 Pfizer Inc.
11.4.1 Pfizer Inc. Company Detail
11.4.2 Pfizer Inc. Business Overview
11.4.3 Pfizer Inc. Kidney & Renal Fibrosis Treatment Introduction
11.4.4 Pfizer Inc. Revenue in Kidney & Renal Fibrosis Treatment Business (2018-2023)
11.4.5 Pfizer Inc. Recent Development
11.5 InterMune Inc.
11.5.1 InterMune Inc. Company Detail
11.5.2 InterMune Inc. Business Overview
11.5.3 InterMune Inc. Kidney & Renal Fibrosis Treatment Introduction
11.5.4 InterMune Inc. Revenue in Kidney & Renal Fibrosis Treatment Business (2018-2023)
11.5.5 InterMune Inc. Recent Development
11.6 ProMetic Life-Sciences Inc.
11.6.1 ProMetic Life-Sciences Inc. Company Detail
11.6.2 ProMetic Life-Sciences Inc. Business Overview
11.6.3 ProMetic Life-Sciences Inc. Kidney & Renal Fibrosis Treatment Introduction
11.6.4 ProMetic Life-Sciences Inc. Revenue in Kidney & Renal Fibrosis Treatment Business (2018-2023)
11.6.5 ProMetic Life-Sciences Inc. Recent Development
11.7 La Jolla Pharmaceutical Company
11.7.1 La Jolla Pharmaceutical Company Company Detail
11.7.2 La Jolla Pharmaceutical Company Business Overview
11.7.3 La Jolla Pharmaceutical Company Kidney & Renal Fibrosis Treatment Introduction
11.7.4 La Jolla Pharmaceutical Company Revenue in Kidney & Renal Fibrosis Treatment Business (2018-2023)
11.7.5 La Jolla Pharmaceutical Company Recent Development
11.8 Genzyme Corporation
11.8.1 Genzyme Corporation Company Detail
11.8.2 Genzyme Corporation Business Overview
11.8.3 Genzyme Corporation Kidney & Renal Fibrosis Treatment Introduction
11.8.4 Genzyme Corporation Revenue in Kidney & Renal Fibrosis Treatment Business (2018-2023)
11.8.5 Genzyme Corporation Recent Development
11.9 BioLine Rx Ltd
11.9.1 BioLine Rx Ltd Company Detail
11.9.2 BioLine Rx Ltd Business Overview
11.9.3 BioLine Rx Ltd Kidney & Renal Fibrosis Treatment Introduction
11.9.4 BioLine Rx Ltd Revenue in Kidney & Renal Fibrosis Treatment Business (2018-2023)
11.9.5 BioLine Rx Ltd Recent Development
12 ANALYST'S VIEWPOINTS/CONCLUSIONS
13 APPENDIX
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Kidney & Renal Fibrosis Treatment Market Size Growth Rate by Type: 2018 VS 2022 VS 2029
1.2.2 Angiotensin II Receptor Blockers (ARBs)
1.2.3 Angiotensin Converting Enzyme (ACE) Inhibitors
1.2.4 Pirfenidone
1.2.5 Renin Inhibitors
1.2.6 Vasopeptidase Inhibitors
1.3 Market by Application
1.3.1 Global Kidney & Renal Fibrosis Treatment Market Growth by Application: 2018 VS 2022 VS 2029
1.3.2 Commercial/Private Hospitals
1.3.3 Public Health Hospitals
1.3.4 Clinics
1.3.5 Home Treatment
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 GLOBAL GROWTH TRENDS
2.1 Global Kidney & Renal Fibrosis Treatment Market Perspective (2018-2029)
2.2 Kidney & Renal Fibrosis Treatment Growth Trends by Region
2.2.1 Global Kidney & Renal Fibrosis Treatment Market Size by Region: 2018 VS 2022 VS 2029
2.2.2 Kidney & Renal Fibrosis Treatment Historic Market Size by Region (2018-2023)
2.2.3 Kidney & Renal Fibrosis Treatment Forecasted Market Size by Region (2024-2029)
2.3 Kidney & Renal Fibrosis Treatment Market Dynamics
2.3.1 Kidney & Renal Fibrosis Treatment Industry Trends
2.3.2 Kidney & Renal Fibrosis Treatment Market Drivers
2.3.3 Kidney & Renal Fibrosis Treatment Market Challenges
2.3.4 Kidney & Renal Fibrosis Treatment Market Restraints
3 COMPETITION LANDSCAPE BY KEY PLAYERS
3.1 Global Top Kidney & Renal Fibrosis Treatment Players by Revenue
3.1.1 Global Top Kidney & Renal Fibrosis Treatment Players by Revenue (2018-2023)
3.1.2 Global Kidney & Renal Fibrosis Treatment Revenue Market Share by Players (2018-2023)
3.2 Global Kidney & Renal Fibrosis Treatment Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Kidney & Renal Fibrosis Treatment Revenue
3.4 Global Kidney & Renal Fibrosis Treatment Market Concentration Ratio
3.4.1 Global Kidney & Renal Fibrosis Treatment Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Kidney & Renal Fibrosis Treatment Revenue in 2022
3.5 Kidney & Renal Fibrosis Treatment Key Players Head office and Area Served
3.6 Key Players Kidney & Renal Fibrosis Treatment Product Solution and Service
3.7 Date of Enter into Kidney & Renal Fibrosis Treatment Market
3.8 Mergers & Acquisitions, Expansion Plans
4 KIDNEY & RENAL FIBROSIS TREATMENT BREAKDOWN DATA BY TYPE
4.1 Global Kidney & Renal Fibrosis Treatment Historic Market Size by Type (2018-2023)
4.2 Global Kidney & Renal Fibrosis Treatment Forecasted Market Size by Type (2024-2029)
5 KIDNEY & RENAL FIBROSIS TREATMENT BREAKDOWN DATA BY APPLICATION
5.1 Global Kidney & Renal Fibrosis Treatment Historic Market Size by Application (2018-2023)
5.2 Global Kidney & Renal Fibrosis Treatment Forecasted Market Size by Application (2024-2029)
6 NORTH AMERICA
6.1 North America Kidney & Renal Fibrosis Treatment Market Size (2018-2029)
6.2 North America Kidney & Renal Fibrosis Treatment Market Growth Rate by Country: 2018 VS 2022 VS 2029
6.3 North America Kidney & Renal Fibrosis Treatment Market Size by Country (2018-2023)
6.4 North America Kidney & Renal Fibrosis Treatment Market Size by Country (2024-2029)
6.5 United States
6.6 Canada
7 EUROPE
7.1 Europe Kidney & Renal Fibrosis Treatment Market Size (2018-2029)
7.2 Europe Kidney & Renal Fibrosis Treatment Market Growth Rate by Country: 2018 VS 2022 VS 2029
7.3 Europe Kidney & Renal Fibrosis Treatment Market Size by Country (2018-2023)
7.4 Europe Kidney & Renal Fibrosis Treatment Market Size by Country (2024-2029)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 ASIA-PACIFIC
8.1 Asia-Pacific Kidney & Renal Fibrosis Treatment Market Size (2018-2029)
8.2 Asia-Pacific Kidney & Renal Fibrosis Treatment Market Growth Rate by Region: 2018 VS 2022 VS 2029
8.3 Asia-Pacific Kidney & Renal Fibrosis Treatment Market Size by Region (2018-2023)
8.4 Asia-Pacific Kidney & Renal Fibrosis Treatment Market Size by Region (2024-2029)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 LATIN AMERICA
9.1 Latin America Kidney & Renal Fibrosis Treatment Market Size (2018-2029)
9.2 Latin America Kidney & Renal Fibrosis Treatment Market Growth Rate by Country: 2018 VS 2022 VS 2029
9.3 Latin America Kidney & Renal Fibrosis Treatment Market Size by Country (2018-2023)
9.4 Latin America Kidney & Renal Fibrosis Treatment Market Size by Country (2024-2029)
9.5 Mexico
9.6 Brazil
10 MIDDLE EAST & AFRICA
10.1 Middle East & Africa Kidney & Renal Fibrosis Treatment Market Size (2018-2029)
10.2 Middle East & Africa Kidney & Renal Fibrosis Treatment Market Growth Rate by Country: 2018 VS 2022 VS 2029
10.3 Middle East & Africa Kidney & Renal Fibrosis Treatment Market Size by Country (2018-2023)
10.4 Middle East & Africa Kidney & Renal Fibrosis Treatment Market Size by Country (2024-2029)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 KEY PLAYERS PROFILES
11.1 Galectin Therapeutics
11.1.1 Galectin Therapeutics Company Detail
11.1.2 Galectin Therapeutics Business Overview
11.1.3 Galectin Therapeutics Kidney & Renal Fibrosis Treatment Introduction
11.1.4 Galectin Therapeutics Revenue in Kidney & Renal Fibrosis Treatment Business (2018-2023)
11.1.5 Galectin Therapeutics Recent Development
11.2 Merck & Co.
11.2.1 Merck & Co. Company Detail
11.2.2 Merck & Co. Business Overview
11.2.3 Merck & Co. Kidney & Renal Fibrosis Treatment Introduction
11.2.4 Merck & Co. Revenue in Kidney & Renal Fibrosis Treatment Business (2018-2023)
11.2.5 Merck & Co. Recent Development
11.3 F. Hoffman-La Roche Ltd.
11.3.1 F. Hoffman-La Roche Ltd. Company Detail
11.3.2 F. Hoffman-La Roche Ltd. Business Overview
11.3.3 F. Hoffman-La Roche Ltd. Kidney & Renal Fibrosis Treatment Introduction
11.3.4 F. Hoffman-La Roche Ltd. Revenue in Kidney & Renal Fibrosis Treatment Business (2018-2023)
11.3.5 F. Hoffman-La Roche Ltd. Recent Development
11.4 Pfizer Inc.
11.4.1 Pfizer Inc. Company Detail
11.4.2 Pfizer Inc. Business Overview
11.4.3 Pfizer Inc. Kidney & Renal Fibrosis Treatment Introduction
11.4.4 Pfizer Inc. Revenue in Kidney & Renal Fibrosis Treatment Business (2018-2023)
11.4.5 Pfizer Inc. Recent Development
11.5 InterMune Inc.
11.5.1 InterMune Inc. Company Detail
11.5.2 InterMune Inc. Business Overview
11.5.3 InterMune Inc. Kidney & Renal Fibrosis Treatment Introduction
11.5.4 InterMune Inc. Revenue in Kidney & Renal Fibrosis Treatment Business (2018-2023)
11.5.5 InterMune Inc. Recent Development
11.6 ProMetic Life-Sciences Inc.
11.6.1 ProMetic Life-Sciences Inc. Company Detail
11.6.2 ProMetic Life-Sciences Inc. Business Overview
11.6.3 ProMetic Life-Sciences Inc. Kidney & Renal Fibrosis Treatment Introduction
11.6.4 ProMetic Life-Sciences Inc. Revenue in Kidney & Renal Fibrosis Treatment Business (2018-2023)
11.6.5 ProMetic Life-Sciences Inc. Recent Development
11.7 La Jolla Pharmaceutical Company
11.7.1 La Jolla Pharmaceutical Company Company Detail
11.7.2 La Jolla Pharmaceutical Company Business Overview
11.7.3 La Jolla Pharmaceutical Company Kidney & Renal Fibrosis Treatment Introduction
11.7.4 La Jolla Pharmaceutical Company Revenue in Kidney & Renal Fibrosis Treatment Business (2018-2023)
11.7.5 La Jolla Pharmaceutical Company Recent Development
11.8 Genzyme Corporation
11.8.1 Genzyme Corporation Company Detail
11.8.2 Genzyme Corporation Business Overview
11.8.3 Genzyme Corporation Kidney & Renal Fibrosis Treatment Introduction
11.8.4 Genzyme Corporation Revenue in Kidney & Renal Fibrosis Treatment Business (2018-2023)
11.8.5 Genzyme Corporation Recent Development
11.9 BioLine Rx Ltd
11.9.1 BioLine Rx Ltd Company Detail
11.9.2 BioLine Rx Ltd Business Overview
11.9.3 BioLine Rx Ltd Kidney & Renal Fibrosis Treatment Introduction
11.9.4 BioLine Rx Ltd Revenue in Kidney & Renal Fibrosis Treatment Business (2018-2023)
11.9.5 BioLine Rx Ltd Recent Development
12 ANALYST'S VIEWPOINTS/CONCLUSIONS
13 APPENDIX
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
LIST OF TABLES
Table 1. Global Kidney & Renal Fibrosis Treatment Market Size Growth Rate by Type (US$ Million): 2018 VS 2022 VS 2029
Table 2. Key Players of Angiotensin II Receptor Blockers (ARBs)
Table 3. Key Players of Angiotensin Converting Enzyme (ACE) Inhibitors
Table 4. Key Players of Pirfenidone
Table 5. Key Players of Renin Inhibitors
Table 6. Key Players of Vasopeptidase Inhibitors
Table 7. Global Kidney & Renal Fibrosis Treatment Market Size Growth by Application (US$ Million): 2018 VS 2022 VS 2029
Table 8. Global Kidney & Renal Fibrosis Treatment Market Size by Region (US$ Million): 2018 VS 2022 VS 2029
Table 9. Global Kidney & Renal Fibrosis Treatment Market Size by Region (2018-2023) & (US$ Million)
Table 10. Global Kidney & Renal Fibrosis Treatment Market Share by Region (2018-2023)
Table 11. Global Kidney & Renal Fibrosis Treatment Forecasted Market Size by Region (2024-2029) & (US$ Million)
Table 12. Global Kidney & Renal Fibrosis Treatment Market Share by Region (2024-2029)
Table 13. Kidney & Renal Fibrosis Treatment Market Trends
Table 14. Kidney & Renal Fibrosis Treatment Market Drivers
Table 15. Kidney & Renal Fibrosis Treatment Market Challenges
Table 16. Kidney & Renal Fibrosis Treatment Market Restraints
Table 17. Global Kidney & Renal Fibrosis Treatment Revenue by Players (2018-2023) & (US$ Million)
Table 18. Global Kidney & Renal Fibrosis Treatment Market Share by Players (2018-2023)
Table 19. Global Top Kidney & Renal Fibrosis Treatment Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Kidney & Renal Fibrosis Treatment as of 2022)
Table 20. Ranking of Global Top Kidney & Renal Fibrosis Treatment Companies by Revenue (US$ Million) in 2022
Table 21. Global 5 Largest Players Market Share by Kidney & Renal Fibrosis Treatment Revenue (CR5 and HHI) & (2018-2023)
Table 22. Key Players Headquarters and Area Served
Table 23. Key Players Kidney & Renal Fibrosis Treatment Product Solution and Service
Table 24. Date of Enter into Kidney & Renal Fibrosis Treatment Market
Table 25. Mergers & Acquisitions, Expansion Plans
Table 26. Global Kidney & Renal Fibrosis Treatment Market Size by Type (2018-2023) & (US$ Million)
Table 27. Global Kidney & Renal Fibrosis Treatment Revenue Market Share by Type (2018-2023)
Table 28. Global Kidney & Renal Fibrosis Treatment Forecasted Market Size by Type (2024-2029) & (US$ Million)
Table 29. Global Kidney & Renal Fibrosis Treatment Revenue Market Share by Type (2024-2029)
Table 30. Global Kidney & Renal Fibrosis Treatment Market Size by Application (2018-2023) & (US$ Million)
Table 31. Global Kidney & Renal Fibrosis Treatment Revenue Market Share by Application (2018-2023)
Table 32. Global Kidney & Renal Fibrosis Treatment Forecasted Market Size by Application (2024-2029) & (US$ Million)
Table 33. Global Kidney & Renal Fibrosis Treatment Revenue Market Share by Application (2024-2029)
Table 34. North America Kidney & Renal Fibrosis Treatment Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029
Table 35. North America Kidney & Renal Fibrosis Treatment Market Size by Country (2018-2023) & (US$ Million)
Table 36. North America Kidney & Renal Fibrosis Treatment Market Size by Country (2024-2029) & (US$ Million)
Table 37. Europe Kidney & Renal Fibrosis Treatment Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029
Table 38. Europe Kidney & Renal Fibrosis Treatment Market Size by Country (2018-2023) & (US$ Million)
Table 39. Europe Kidney & Renal Fibrosis Treatment Market Size by Country (2024-2029) & (US$ Million)
Table 40. Asia-Pacific Kidney & Renal Fibrosis Treatment Market Size Growth Rate by Region (US$ Million): 2018 VS 2022 VS 2029
Table 41. Asia-Pacific Kidney & Renal Fibrosis Treatment Market Size by Region (2018-2023) & (US$ Million)
Table 42. Asia-Pacific Kidney & Renal Fibrosis Treatment Market Size by Region (2024-2029) & (US$ Million)
Table 43. Latin America Kidney & Renal Fibrosis Treatment Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029
Table 44. Latin America Kidney & Renal Fibrosis Treatment Market Size by Country (2018-2023) & (US$ Million)
Table 45. Latin America Kidney & Renal Fibrosis Treatment Market Size by Country (2024-2029) & (US$ Million)
Table 46. Middle East & Africa Kidney & Renal Fibrosis Treatment Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029
Table 47. Middle East & Africa Kidney & Renal Fibrosis Treatment Market Size by Country (2018-2023) & (US$ Million)
Table 48. Middle East & Africa Kidney & Renal Fibrosis Treatment Market Size by Country (2024-2029) & (US$ Million)
Table 49. Galectin Therapeutics Company Detail
Table 50. Galectin Therapeutics Business Overview
Table 51. Galectin Therapeutics Kidney & Renal Fibrosis Treatment Product
Table 52. Galectin Therapeutics Revenue in Kidney & Renal Fibrosis Treatment Business (2018-2023) & (US$ Million)
Table 53. Galectin Therapeutics Recent Development
Table 54. Merck & Co. Company Detail
Table 55. Merck & Co. Business Overview
Table 56. Merck & Co. Kidney & Renal Fibrosis Treatment Product
Table 57. Merck & Co. Revenue in Kidney & Renal Fibrosis Treatment Business (2018-2023) & (US$ Million)
Table 58. Merck & Co. Recent Development
Table 59. F. Hoffman-La Roche Ltd. Company Detail
Table 60. F. Hoffman-La Roche Ltd. Business Overview
Table 61. F. Hoffman-La Roche Ltd. Kidney & Renal Fibrosis Treatment Product
Table 62. F. Hoffman-La Roche Ltd. Revenue in Kidney & Renal Fibrosis Treatment Business (2018-2023) & (US$ Million)
Table 63. F. Hoffman-La Roche Ltd. Recent Development
Table 64. Pfizer Inc. Company Detail
Table 65. Pfizer Inc. Business Overview
Table 66. Pfizer Inc. Kidney & Renal Fibrosis Treatment Product
Table 67. Pfizer Inc. Revenue in Kidney & Renal Fibrosis Treatment Business (2018-2023) & (US$ Million)
Table 68. Pfizer Inc. Recent Development
Table 69. InterMune Inc. Company Detail
Table 70. InterMune Inc. Business Overview
Table 71. InterMune Inc. Kidney & Renal Fibrosis Treatment Product
Table 72. InterMune Inc. Revenue in Kidney & Renal Fibrosis Treatment Business (2018-2023) & (US$ Million)
Table 73. InterMune Inc. Recent Development
Table 74. ProMetic Life-Sciences Inc. Company Detail
Table 75. ProMetic Life-Sciences Inc. Business Overview
Table 76. ProMetic Life-Sciences Inc. Kidney & Renal Fibrosis Treatment Product
Table 77. ProMetic Life-Sciences Inc. Revenue in Kidney & Renal Fibrosis Treatment Business (2018-2023) & (US$ Million)
Table 78. ProMetic Life-Sciences Inc. Recent Development
Table 79. La Jolla Pharmaceutical Company Company Detail
Table 80. La Jolla Pharmaceutical Company Business Overview
Table 81. La Jolla Pharmaceutical Company Kidney & Renal Fibrosis Treatment Product
Table 82. La Jolla Pharmaceutical Company Revenue in Kidney & Renal Fibrosis Treatment Business (2018-2023) & (US$ Million)
Table 83. La Jolla Pharmaceutical Company Recent Development
Table 84. Genzyme Corporation Company Detail
Table 85. Genzyme Corporation Business Overview
Table 86. Genzyme Corporation Kidney & Renal Fibrosis Treatment Product
Table 87. Genzyme Corporation Revenue in Kidney & Renal Fibrosis Treatment Business (2018-2023) & (US$ Million)
Table 88. Genzyme Corporation Recent Development
Table 89. BioLine Rx Ltd Company Detail
Table 90. BioLine Rx Ltd Business Overview
Table 91. BioLine Rx Ltd Kidney & Renal Fibrosis Treatment Product
Table 92. BioLine Rx Ltd Revenue in Kidney & Renal Fibrosis Treatment Business (2018-2023) & (US$ Million)
Table 93. BioLine Rx Ltd Recent Development
Table 94. Research Programs/Design for This Report
Table 95. Key Data Information from Secondary Sources
Table 96. Key Data Information from Primary Sources
Table 1. Global Kidney & Renal Fibrosis Treatment Market Size Growth Rate by Type (US$ Million): 2018 VS 2022 VS 2029
Table 2. Key Players of Angiotensin II Receptor Blockers (ARBs)
Table 3. Key Players of Angiotensin Converting Enzyme (ACE) Inhibitors
Table 4. Key Players of Pirfenidone
Table 5. Key Players of Renin Inhibitors
Table 6. Key Players of Vasopeptidase Inhibitors
Table 7. Global Kidney & Renal Fibrosis Treatment Market Size Growth by Application (US$ Million): 2018 VS 2022 VS 2029
Table 8. Global Kidney & Renal Fibrosis Treatment Market Size by Region (US$ Million): 2018 VS 2022 VS 2029
Table 9. Global Kidney & Renal Fibrosis Treatment Market Size by Region (2018-2023) & (US$ Million)
Table 10. Global Kidney & Renal Fibrosis Treatment Market Share by Region (2018-2023)
Table 11. Global Kidney & Renal Fibrosis Treatment Forecasted Market Size by Region (2024-2029) & (US$ Million)
Table 12. Global Kidney & Renal Fibrosis Treatment Market Share by Region (2024-2029)
Table 13. Kidney & Renal Fibrosis Treatment Market Trends
Table 14. Kidney & Renal Fibrosis Treatment Market Drivers
Table 15. Kidney & Renal Fibrosis Treatment Market Challenges
Table 16. Kidney & Renal Fibrosis Treatment Market Restraints
Table 17. Global Kidney & Renal Fibrosis Treatment Revenue by Players (2018-2023) & (US$ Million)
Table 18. Global Kidney & Renal Fibrosis Treatment Market Share by Players (2018-2023)
Table 19. Global Top Kidney & Renal Fibrosis Treatment Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Kidney & Renal Fibrosis Treatment as of 2022)
Table 20. Ranking of Global Top Kidney & Renal Fibrosis Treatment Companies by Revenue (US$ Million) in 2022
Table 21. Global 5 Largest Players Market Share by Kidney & Renal Fibrosis Treatment Revenue (CR5 and HHI) & (2018-2023)
Table 22. Key Players Headquarters and Area Served
Table 23. Key Players Kidney & Renal Fibrosis Treatment Product Solution and Service
Table 24. Date of Enter into Kidney & Renal Fibrosis Treatment Market
Table 25. Mergers & Acquisitions, Expansion Plans
Table 26. Global Kidney & Renal Fibrosis Treatment Market Size by Type (2018-2023) & (US$ Million)
Table 27. Global Kidney & Renal Fibrosis Treatment Revenue Market Share by Type (2018-2023)
Table 28. Global Kidney & Renal Fibrosis Treatment Forecasted Market Size by Type (2024-2029) & (US$ Million)
Table 29. Global Kidney & Renal Fibrosis Treatment Revenue Market Share by Type (2024-2029)
Table 30. Global Kidney & Renal Fibrosis Treatment Market Size by Application (2018-2023) & (US$ Million)
Table 31. Global Kidney & Renal Fibrosis Treatment Revenue Market Share by Application (2018-2023)
Table 32. Global Kidney & Renal Fibrosis Treatment Forecasted Market Size by Application (2024-2029) & (US$ Million)
Table 33. Global Kidney & Renal Fibrosis Treatment Revenue Market Share by Application (2024-2029)
Table 34. North America Kidney & Renal Fibrosis Treatment Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029
Table 35. North America Kidney & Renal Fibrosis Treatment Market Size by Country (2018-2023) & (US$ Million)
Table 36. North America Kidney & Renal Fibrosis Treatment Market Size by Country (2024-2029) & (US$ Million)
Table 37. Europe Kidney & Renal Fibrosis Treatment Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029
Table 38. Europe Kidney & Renal Fibrosis Treatment Market Size by Country (2018-2023) & (US$ Million)
Table 39. Europe Kidney & Renal Fibrosis Treatment Market Size by Country (2024-2029) & (US$ Million)
Table 40. Asia-Pacific Kidney & Renal Fibrosis Treatment Market Size Growth Rate by Region (US$ Million): 2018 VS 2022 VS 2029
Table 41. Asia-Pacific Kidney & Renal Fibrosis Treatment Market Size by Region (2018-2023) & (US$ Million)
Table 42. Asia-Pacific Kidney & Renal Fibrosis Treatment Market Size by Region (2024-2029) & (US$ Million)
Table 43. Latin America Kidney & Renal Fibrosis Treatment Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029
Table 44. Latin America Kidney & Renal Fibrosis Treatment Market Size by Country (2018-2023) & (US$ Million)
Table 45. Latin America Kidney & Renal Fibrosis Treatment Market Size by Country (2024-2029) & (US$ Million)
Table 46. Middle East & Africa Kidney & Renal Fibrosis Treatment Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029
Table 47. Middle East & Africa Kidney & Renal Fibrosis Treatment Market Size by Country (2018-2023) & (US$ Million)
Table 48. Middle East & Africa Kidney & Renal Fibrosis Treatment Market Size by Country (2024-2029) & (US$ Million)
Table 49. Galectin Therapeutics Company Detail
Table 50. Galectin Therapeutics Business Overview
Table 51. Galectin Therapeutics Kidney & Renal Fibrosis Treatment Product
Table 52. Galectin Therapeutics Revenue in Kidney & Renal Fibrosis Treatment Business (2018-2023) & (US$ Million)
Table 53. Galectin Therapeutics Recent Development
Table 54. Merck & Co. Company Detail
Table 55. Merck & Co. Business Overview
Table 56. Merck & Co. Kidney & Renal Fibrosis Treatment Product
Table 57. Merck & Co. Revenue in Kidney & Renal Fibrosis Treatment Business (2018-2023) & (US$ Million)
Table 58. Merck & Co. Recent Development
Table 59. F. Hoffman-La Roche Ltd. Company Detail
Table 60. F. Hoffman-La Roche Ltd. Business Overview
Table 61. F. Hoffman-La Roche Ltd. Kidney & Renal Fibrosis Treatment Product
Table 62. F. Hoffman-La Roche Ltd. Revenue in Kidney & Renal Fibrosis Treatment Business (2018-2023) & (US$ Million)
Table 63. F. Hoffman-La Roche Ltd. Recent Development
Table 64. Pfizer Inc. Company Detail
Table 65. Pfizer Inc. Business Overview
Table 66. Pfizer Inc. Kidney & Renal Fibrosis Treatment Product
Table 67. Pfizer Inc. Revenue in Kidney & Renal Fibrosis Treatment Business (2018-2023) & (US$ Million)
Table 68. Pfizer Inc. Recent Development
Table 69. InterMune Inc. Company Detail
Table 70. InterMune Inc. Business Overview
Table 71. InterMune Inc. Kidney & Renal Fibrosis Treatment Product
Table 72. InterMune Inc. Revenue in Kidney & Renal Fibrosis Treatment Business (2018-2023) & (US$ Million)
Table 73. InterMune Inc. Recent Development
Table 74. ProMetic Life-Sciences Inc. Company Detail
Table 75. ProMetic Life-Sciences Inc. Business Overview
Table 76. ProMetic Life-Sciences Inc. Kidney & Renal Fibrosis Treatment Product
Table 77. ProMetic Life-Sciences Inc. Revenue in Kidney & Renal Fibrosis Treatment Business (2018-2023) & (US$ Million)
Table 78. ProMetic Life-Sciences Inc. Recent Development
Table 79. La Jolla Pharmaceutical Company Company Detail
Table 80. La Jolla Pharmaceutical Company Business Overview
Table 81. La Jolla Pharmaceutical Company Kidney & Renal Fibrosis Treatment Product
Table 82. La Jolla Pharmaceutical Company Revenue in Kidney & Renal Fibrosis Treatment Business (2018-2023) & (US$ Million)
Table 83. La Jolla Pharmaceutical Company Recent Development
Table 84. Genzyme Corporation Company Detail
Table 85. Genzyme Corporation Business Overview
Table 86. Genzyme Corporation Kidney & Renal Fibrosis Treatment Product
Table 87. Genzyme Corporation Revenue in Kidney & Renal Fibrosis Treatment Business (2018-2023) & (US$ Million)
Table 88. Genzyme Corporation Recent Development
Table 89. BioLine Rx Ltd Company Detail
Table 90. BioLine Rx Ltd Business Overview
Table 91. BioLine Rx Ltd Kidney & Renal Fibrosis Treatment Product
Table 92. BioLine Rx Ltd Revenue in Kidney & Renal Fibrosis Treatment Business (2018-2023) & (US$ Million)
Table 93. BioLine Rx Ltd Recent Development
Table 94. Research Programs/Design for This Report
Table 95. Key Data Information from Secondary Sources
Table 96. Key Data Information from Primary Sources
LIST OF FIGURES
Figure 1. Global Kidney & Renal Fibrosis Treatment Market Size Comparison by Type (2023-2029) & (US$ Million)
Figure 2. Global Kidney & Renal Fibrosis Treatment Market Share by Type: 2022 VS 2029
Figure 3. Angiotensin II Receptor Blockers (ARBs) Features
Figure 4. Angiotensin Converting Enzyme (ACE) Inhibitors Features
Figure 5. Pirfenidone Features
Figure 6. Renin Inhibitors Features
Figure 7. Vasopeptidase Inhibitors Features
Figure 8. Global Kidney & Renal Fibrosis Treatment Market Size Comparison by Application (2023-2029) & (US$ Million)
Figure 9. Global Kidney & Renal Fibrosis Treatment Market Share by Application: 2022 VS 2029
Figure 10. Commercial/Private Hospitals Case Studies
Figure 11. Public Health Hospitals Case Studies
Figure 12. Clinics Case Studies
Figure 13. Home Treatment Case Studies
Figure 14. Kidney & Renal Fibrosis Treatment Report Years Considered
Figure 15. Global Kidney & Renal Fibrosis Treatment Market Size (US$ Million), Year-over-Year: 2018-2029
Figure 16. Global Kidney & Renal Fibrosis Treatment Market Size, (US$ Million), 2018 VS 2022 VS 2029
Figure 17. Global Kidney & Renal Fibrosis Treatment Market Share by Region: 2022 VS 2029
Figure 18. Global Kidney & Renal Fibrosis Treatment Market Share by Players in 2022
Figure 19. Global Top Kidney & Renal Fibrosis Treatment Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Kidney & Renal Fibrosis Treatment as of 2022)
Figure 20. The Top 10 and 5 Players Market Share by Kidney & Renal Fibrosis Treatment Revenue in 2022
Figure 21. North America Kidney & Renal Fibrosis Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 22. North America Kidney & Renal Fibrosis Treatment Market Share by Country (2018-2029)
Figure 23. United States Kidney & Renal Fibrosis Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 24. Canada Kidney & Renal Fibrosis Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 25. Europe Kidney & Renal Fibrosis Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 26. Europe Kidney & Renal Fibrosis Treatment Market Share by Country (2018-2029)
Figure 27. Germany Kidney & Renal Fibrosis Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 28. France Kidney & Renal Fibrosis Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 29. U.K. Kidney & Renal Fibrosis Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 30. Italy Kidney & Renal Fibrosis Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 31. Russia Kidney & Renal Fibrosis Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 32. Nordic Countries Kidney & Renal Fibrosis Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 33. Asia-Pacific Kidney & Renal Fibrosis Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 34. Asia-Pacific Kidney & Renal Fibrosis Treatment Market Share by Region (2018-2029)
Figure 35. China Kidney & Renal Fibrosis Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 36. Japan Kidney & Renal Fibrosis Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 37. South Korea Kidney & Renal Fibrosis Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 38. Southeast Asia Kidney & Renal Fibrosis Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 39. India Kidney & Renal Fibrosis Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 40. Australia Kidney & Renal Fibrosis Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 41. Latin America Kidney & Renal Fibrosis Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 42. Latin America Kidney & Renal Fibrosis Treatment Market Share by Country (2018-2029)
Figure 43. Mexico Kidney & Renal Fibrosis Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 44. Brazil Kidney & Renal Fibrosis Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 45. Middle East & Africa Kidney & Renal Fibrosis Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 46. Middle East & Africa Kidney & Renal Fibrosis Treatment Market Share by Country (2018-2029)
Figure 47. Turkey Kidney & Renal Fibrosis Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 48. Saudi Arabia Kidney & Renal Fibrosis Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 49. Galectin Therapeutics Revenue Growth Rate in Kidney & Renal Fibrosis Treatment Business (2018-2023)
Figure 50. Merck & Co. Revenue Growth Rate in Kidney & Renal Fibrosis Treatment Business (2018-2023)
Figure 51. F. Hoffman-La Roche Ltd. Revenue Growth Rate in Kidney & Renal Fibrosis Treatment Business (2018-2023)
Figure 52. Pfizer Inc. Revenue Growth Rate in Kidney & Renal Fibrosis Treatment Business (2018-2023)
Figure 53. InterMune Inc. Revenue Growth Rate in Kidney & Renal Fibrosis Treatment Business (2018-2023)
Figure 54. ProMetic Life-Sciences Inc. Revenue Growth Rate in Kidney & Renal Fibrosis Treatment Business (2018-2023)
Figure 55. La Jolla Pharmaceutical Company Revenue Growth Rate in Kidney & Renal Fibrosis Treatment Business (2018-2023)
Figure 56. Genzyme Corporation Revenue Growth Rate in Kidney & Renal Fibrosis Treatment Business (2018-2023)
Figure 57. BioLine Rx Ltd Revenue Growth Rate in Kidney & Renal Fibrosis Treatment Business (2018-2023)
Figure 58. Bottom-up and Top-down Approaches for This Report
Figure 59. Data Triangulation
Figure 60. Key Executives Interviewed
Figure 1. Global Kidney & Renal Fibrosis Treatment Market Size Comparison by Type (2023-2029) & (US$ Million)
Figure 2. Global Kidney & Renal Fibrosis Treatment Market Share by Type: 2022 VS 2029
Figure 3. Angiotensin II Receptor Blockers (ARBs) Features
Figure 4. Angiotensin Converting Enzyme (ACE) Inhibitors Features
Figure 5. Pirfenidone Features
Figure 6. Renin Inhibitors Features
Figure 7. Vasopeptidase Inhibitors Features
Figure 8. Global Kidney & Renal Fibrosis Treatment Market Size Comparison by Application (2023-2029) & (US$ Million)
Figure 9. Global Kidney & Renal Fibrosis Treatment Market Share by Application: 2022 VS 2029
Figure 10. Commercial/Private Hospitals Case Studies
Figure 11. Public Health Hospitals Case Studies
Figure 12. Clinics Case Studies
Figure 13. Home Treatment Case Studies
Figure 14. Kidney & Renal Fibrosis Treatment Report Years Considered
Figure 15. Global Kidney & Renal Fibrosis Treatment Market Size (US$ Million), Year-over-Year: 2018-2029
Figure 16. Global Kidney & Renal Fibrosis Treatment Market Size, (US$ Million), 2018 VS 2022 VS 2029
Figure 17. Global Kidney & Renal Fibrosis Treatment Market Share by Region: 2022 VS 2029
Figure 18. Global Kidney & Renal Fibrosis Treatment Market Share by Players in 2022
Figure 19. Global Top Kidney & Renal Fibrosis Treatment Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Kidney & Renal Fibrosis Treatment as of 2022)
Figure 20. The Top 10 and 5 Players Market Share by Kidney & Renal Fibrosis Treatment Revenue in 2022
Figure 21. North America Kidney & Renal Fibrosis Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 22. North America Kidney & Renal Fibrosis Treatment Market Share by Country (2018-2029)
Figure 23. United States Kidney & Renal Fibrosis Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 24. Canada Kidney & Renal Fibrosis Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 25. Europe Kidney & Renal Fibrosis Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 26. Europe Kidney & Renal Fibrosis Treatment Market Share by Country (2018-2029)
Figure 27. Germany Kidney & Renal Fibrosis Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 28. France Kidney & Renal Fibrosis Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 29. U.K. Kidney & Renal Fibrosis Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 30. Italy Kidney & Renal Fibrosis Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 31. Russia Kidney & Renal Fibrosis Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 32. Nordic Countries Kidney & Renal Fibrosis Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 33. Asia-Pacific Kidney & Renal Fibrosis Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 34. Asia-Pacific Kidney & Renal Fibrosis Treatment Market Share by Region (2018-2029)
Figure 35. China Kidney & Renal Fibrosis Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 36. Japan Kidney & Renal Fibrosis Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 37. South Korea Kidney & Renal Fibrosis Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 38. Southeast Asia Kidney & Renal Fibrosis Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 39. India Kidney & Renal Fibrosis Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 40. Australia Kidney & Renal Fibrosis Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 41. Latin America Kidney & Renal Fibrosis Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 42. Latin America Kidney & Renal Fibrosis Treatment Market Share by Country (2018-2029)
Figure 43. Mexico Kidney & Renal Fibrosis Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 44. Brazil Kidney & Renal Fibrosis Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 45. Middle East & Africa Kidney & Renal Fibrosis Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 46. Middle East & Africa Kidney & Renal Fibrosis Treatment Market Share by Country (2018-2029)
Figure 47. Turkey Kidney & Renal Fibrosis Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 48. Saudi Arabia Kidney & Renal Fibrosis Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 49. Galectin Therapeutics Revenue Growth Rate in Kidney & Renal Fibrosis Treatment Business (2018-2023)
Figure 50. Merck & Co. Revenue Growth Rate in Kidney & Renal Fibrosis Treatment Business (2018-2023)
Figure 51. F. Hoffman-La Roche Ltd. Revenue Growth Rate in Kidney & Renal Fibrosis Treatment Business (2018-2023)
Figure 52. Pfizer Inc. Revenue Growth Rate in Kidney & Renal Fibrosis Treatment Business (2018-2023)
Figure 53. InterMune Inc. Revenue Growth Rate in Kidney & Renal Fibrosis Treatment Business (2018-2023)
Figure 54. ProMetic Life-Sciences Inc. Revenue Growth Rate in Kidney & Renal Fibrosis Treatment Business (2018-2023)
Figure 55. La Jolla Pharmaceutical Company Revenue Growth Rate in Kidney & Renal Fibrosis Treatment Business (2018-2023)
Figure 56. Genzyme Corporation Revenue Growth Rate in Kidney & Renal Fibrosis Treatment Business (2018-2023)
Figure 57. BioLine Rx Ltd Revenue Growth Rate in Kidney & Renal Fibrosis Treatment Business (2018-2023)
Figure 58. Bottom-up and Top-down Approaches for This Report
Figure 59. Data Triangulation
Figure 60. Key Executives Interviewed
